Growing China’s capacity to conduct high-quality trials

As more companies conduct clinical trials in China, they are facing increasingly steep competition for patients and PIs at the country’s small number of established clinical trial centers. To break the logjam and tap a larger portion of China’s huge patient population, some sponsors and CROs are cautiously working new sites into their networks.

The challenge is not sacrificing data quality at a time when Chinese companies are just beginning to convince the world that they can produce high-caliber clinical research...